Cargando…
Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients
Background: N6-methyladenosine (m6A) is the most common form of mRNA- and long noncoding RNA (lncRNA)-specific internal modification encountered in eukaryotes, with important effects on mRNA stability, translation, and splicing. The role of m6A-modified lncRNAs (m6A-lncRNAs) in bladder cancer (BLCA)...
Autores principales: | Huang, Xin, Wang, Hao-Fei, Huang, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428265/ https://www.ncbi.nlm.nih.gov/pubmed/36061188 http://dx.doi.org/10.3389/fgene.2022.906880 |
Ejemplares similares
-
N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022) -
N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients
por: Xu, Shuyu, et al.
Publicado: (2022) -
N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022) -
The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020) -
N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)